Globus Medical

Yahoo Finance • 9 days ago

Merit Medical Systems, Globus Medical, Tenet Healthcare, Progyny, and IQVIA Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story

Yahoo Finance • 20 days ago

GMED Crosses Above Average Analyst Target

In recent trading, shares of Globus Medical Inc (Symbol: GMED) have crossed above the average analyst 12-month target price of $71.55, changing hands for $71.78/share. When a stock reaches the target an analyst has set, the analyst logica... Full story

Yahoo Finance • 21 days ago

Globus Medical (GMED) Soars 38.9% on Stellar Q3

We recently published 10 Stocks Soaring Past Expectations. Globus Medical Inc. (NYSE:GMED) is one of the big names that led last week’s charge. Globus Medical soared by 38.9 percent week-on-week as investors took path from bullish analyst... Full story

Yahoo Finance • 23 days ago

Today’s Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical

Thinkstock Quick Read Affirm (AFRM) reported EPS of 23 cents and beat estimates by 12 cents on revenue of $933M. Affirm raised its GMV guidance to $47.5B from $46B and increased adjusted operating margin outlook to 27.1%. Expedia (EXPE)... Full story

Yahoo Finance • 24 days ago

Globus Medical raises 2025 EPS guidance to $3.75–$3.85 as Nevro integration accelerates profitability

Earnings Call Insights: Globus Medical (GMED) Q3 2025 MANAGEMENT VIEW * CEO Keith Pfeil opened with, "We are extremely pleased with our overall Q3 performance, delivering sales of $769 million and non-GAAP diluted earnings per share of... Full story

Yahoo Finance • 24 days ago

Globus Medical Reports Third Quarter 2025 Results

AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025. Worldwide net sales were $76... Full story

Yahoo Finance • 26 days ago

Globus Medical (GMED) Q3 Earnings: What To Expect

Medical device company Globus Medical (NYSE:GMED) will be reporting results this Thursday after market hours. Here’s what investors should know. Globus Medical beat analysts’ revenue expectations by 0.7% last quarter, reporting revenues o... Full story

Yahoo Finance • last month

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

AUDUBON, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2025 after the market close on... Full story

Yahoo Finance • 2 months ago

Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma

AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio design... Full story

Yahoo Finance • 2 months ago

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 2 months ago

Robotic Neurosurgery Market Analysis and Forecast Report 2025-2035, with Profiles of Brainlab, Renishaw, Zimmer Biomet, Medical Microinstruments, Monteris Medical, Medtronic, Globus Medical, & Accuray

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Robotic Neurosurgery Market - A Global and Regional Analysis: Focus on Application, Product Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added t... Full story

Yahoo Finance • 3 months ago

Globus Medical wins favorable jury verdict in patent dispute with Life Spine

[Gavel on desk] CatLane A Delaware jury has sided with Globus Medical (NYSE:GMED [https://seekingalpha.com/symbol/GMED]), issuing a verdict in favor of the orthopedic product maker in a patent infringement case against its rival Life Spin... Full story

Yahoo Finance • 3 months ago

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigati... Full story

Yahoo Finance • 3 months ago

Citizens JMP reiterates Market Perform rating on Globus Medical stock

Investing.com - Citizens JMP has reiterated its Market Perform rating on Globus Medical (NYSE:GMED) following the release of the company’s second-quarter 2025 results. According to InvestingPro analysis, the company currently appears und... Full story

Yahoo Finance • 4 months ago

Globus Medical Inc - A (NYSE:GMED): A Prime Example of Affordable Growth with Strong Fundamentals

Growth investing typically focuses on companies with significant revenue and earnings increases, though prices may sometimes reach unrealistic heights. The "Affordable Growth" method seeks to strike a balance by selecting stocks with solid... Full story

Yahoo Finance • 4 months ago

Barclays raises Globus Medical stock price target to $106 on margin strength

Investing.com - Barclays raised its price target on Globus Medical (NYSE:GMED) to $106.00 from $103.00 on Friday, while maintaining an Overweight rating on the medical device company’s stock. According to InvestingPro data, the stock cur... Full story

Yahoo Finance • 4 months ago

Globus Medical earnings beat by $0.10, revenue topped estimates

Investing.com - Globus Medical (NYSE: GMED) reported second quarter EPS of $0.86, $0.10 better than the analyst estimate of $0.76. Revenue for the quarter came in at $745.3M versus the consensus estimate of $739.16M. Guidance Globus Me... Full story

Yahoo Finance • 4 months ago

Globus Medical Reports Second Quarter 2025 Results

AUDUBON, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025. Worldwide net sales were $745.3 m... Full story

Yahoo Finance • 4 months ago

Square, Gilead, Monster Beverage set to report earnings Thursday

Earnings season continues as we highlight companies expected to report earnings the next trading day, helping investors prepare for the upcoming market action. Leading the charge are Square, Gilead Sciences, and Monster Beverage (NASDAQ:... Full story

Yahoo Finance • 4 months ago

Canaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy Rating

Globus Medical Inc. (NYSE:GMED) is one of the most undervalued stocks to buy and hold for 3 years. On July 22, Canaccord reduced its price target for Globus Medical from $97 to $90 while maintaining a Buy rating. The adjustment showed Cana... Full story